Please assess the completion status of the following clinical trial:

Trial Title: Sacral Nerve Stimulation Therapy for the Treatment of Chronic Fecal Incontinence

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Signed and dated informed consent.~* 18 years of age or older.~* Patient is diagnosed with chronic fecal incontinence of a duration greater than 6 months (\>12 months post-vaginal childbirth) and defined as \> 2 incontinent episodes on average per week of more than staining recorded during the baseline diary period.~* Failed or are not candidates for more conservative treatments.~* Willing and competent to completely and accurately fill out bowel diaries and questionnaires throughout the study.~Exclusion Criteria:~* Congenital anorectal malformations.~* Active participation in another bowel disorder investigational study.~* Present rectal prolapse.~* Previous rectal surgery (such as rectopexy or resection) or sphincteroplasty done \< 12 months prior to study enrollment (24 months for cancer).~* Neurological diseases such as clinically significant peripheral neuropathy or complete spinal cord injury (i.e. paraplegia).~* Grade III hemorrhoids.~* Known or suspected organic disorders of the bowel (i.e. Inflammatory bowel disease such as Crohn's or ulcerative colitis).~* Chronic watery diarrhea, unmanageable by drugs or diet, as primary cause of fecal incontinence. (Incontinent episodes with a Bristol stool consistency of \> 6 for \> 4 days during the baseline diary period will be exclusionary, unless the investigator determines that the diary is not indicative of chronic watery diarrhea.)~* Pregnancy or planned pregnancy.~* Patients for whom patient materials are not available in a language understood by the patient.~* Life expectancy of less than one year.~* Patient characteristics indicating a poor understanding of the study or poor compliance with the study protocol (i.e., patients unable to adequately operate equipment, patients unwilling or unable to return for scheduled follow-up visits).~* Patients with a history of pelvic irradiation who present with visible or functional effects of irradiation.~* Patients with active anal abscesses or fistulas.~* Patients with anatomical limitations that would prevent the successful placement of an electrode.~* Patients with knowledge of planned MRIs, diathermy, microwave, or RF energy.~* Patients with other implantable neurostimulators, pacemakers or defibrillators.~* Defect of external anal sphincter of \>60 degrees or amenable to surgical repair.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).